Source: Dionex Corporation
Friday, March 19, 2010
March 2010, Sunnyvale, CA—Dionex Corporation is pleased to announce the addition of a new Acclaim
®
HILIC column designed for
separating highly hydrophilic analytes by hydrophilic interaction liquid chromatography (HILIC).
advertisement
The new Acclaim HILIC column is based on high-purity, spherical, porous silica gel that is covalently modified with a proprietary
neutral hydrophilic layer. It was created for broad range of applications including the separation of highly hydrophilic drugs and drug
metabolites. The Acclaim HILIC column has a unique mix of features including:
-
Retention of highly polar molecules that are not retained by reversed-phase media
-
Unique selectivity, complementary to reversed-phase columns
-
Hydrolytical stability
-
Rugged column packing
-
Wide application range
The Acclaim HILIC columns include 3 µm particle size in 2.1 × 150 mm, 3.0 × 150 mm, and 4.6 × 150 mm formats, and the Acclaim
RSLC HILIC column is 2.2 µm, 2.1 × 150 mm.
Dionex (NASDAQ:DNEX) is a global leader in the manufacturing and marketing of liquid chromatography and sample preparation
systems, consumables, and software for chemical analysis. The company’s systems are used worldwide in environmental analysis and
by the life sciences, chemical, petrochemical, food and beverage, power generation, and electronics industries. Our expertise in ap-
plications and instrumentation helps analytical scientists to evaluate and develop pharmaceuticals, establish environmental regulations,
and produce better industrial products.
Acclaim is a registered trademark of Dionex Corporation.
###